Neuren Pharmaceuticals Ltd
ASX:NEU
Neuren Pharmaceuticals Ltd
ASX:NEU
Price:
11.78
AUD
-0.59%
Market Closed
Market Cap:
AU$1.5B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Neuren Pharmaceuticals Ltd
ASX:NEU
|
AU |
|
S
|
SCI Pharmtech Inc
TWSE:4119
|
TW |
|
Kirloskar Pneumatic Company Ltd
NSE:KIRLPNU
|
IN |
|
K
|
Kri Kri Milk Industry SA
ATHEX:KRI
|
GR |
|
LBT Innovations Ltd
ASX:LBT
|
AU |
|
E
|
eToro Group Ltd
NASDAQ:ETOR
|
IL |
|
Hawkins Inc
NASDAQ:HWKN
|
US |
|
S
|
Swarna Securities Ltd
BSE:531003
|
IN |
|
Zhe Jiang Taihua New Material Co Ltd
SSE:603055
|
CN |
|
H
|
Hamat Group Ltd
TASE:HAMAT
|
IL |
Income Statement
Earnings Waterfall
Neuren Pharmaceuticals Ltd
Neuren Pharmaceuticals Ltd
Income Statement
Neuren Pharmaceuticals Ltd
Neuren Pharmaceuticals Ltd
Currency: AUD
| Dec-2006 | Jun-2007 | Dec-2007 | Jun-2008 | Dec-2008 | Jun-2009 | Dec-2009 | Jun-2010 | Dec-2010 | Jun-2011 | Dec-2011 | Jun-2012 | Dec-2012 | Jun-2013 | Dec-2013 | Jun-2014 | Dec-2014 | Jun-2015 | Dec-2015 | Jun-2016 | Dec-2016 | Jun-2017 | Dec-2017 | Jun-2018 | Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
2
N/A
|
2
-15%
|
2
+41%
|
3
+29%
|
2
-12%
|
1
-49%
|
5
+304%
|
8
+53%
|
5
-36%
|
4
-13%
|
3
-22%
|
3
+2%
|
4
+29%
|
5
+14%
|
5
+1%
|
4
-21%
|
3
-11%
|
4
+2%
|
2
-44%
|
1
-75%
|
1
+193%
|
1
-19%
|
0
-96%
|
0
+53%
|
14
+19 014%
|
14
+1%
|
0
-97%
|
0
-39%
|
1
+262%
|
0
-90%
|
3
+3 665%
|
0
-98%
|
16
+21 856%
|
79
+402%
|
238
+199%
|
204
-14%
|
224
+10%
|
229
+2%
|
77
-66%
|
|
| Operating Income | ||||||||||||||||||||||||||||||||||||||||
| Operating Expenses |
(12)
|
(14)
|
(14)
|
(12)
|
(12)
|
(14)
|
(5)
|
(8)
|
(10)
|
(7)
|
(8)
|
(10)
|
(9)
|
(11)
|
(11)
|
(12)
|
(13)
|
(15)
|
(17)
|
(17)
|
(13)
|
(8)
|
(6)
|
(6)
|
(8)
|
(12)
|
(11)
|
(8)
|
(10)
|
(12)
|
(11)
|
(7)
|
(16)
|
(24)
|
(33)
|
(38)
|
(38)
|
(35)
|
(43)
|
|
| Selling, General & Administrative |
(3)
|
(3)
|
(3)
|
(3)
|
(2)
|
(2)
|
(1)
|
(2)
|
(2)
|
(1)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(2)
|
(2)
|
(2)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(4)
|
(6)
|
(5)
|
(5)
|
(5)
|
(6)
|
|
| Research & Development |
(8)
|
(11)
|
(10)
|
(8)
|
(9)
|
(6)
|
(3)
|
(6)
|
(7)
|
(6)
|
(5)
|
(6)
|
(6)
|
(8)
|
(8)
|
(9)
|
(10)
|
(12)
|
(14)
|
(14)
|
(13)
|
(9)
|
(5)
|
(6)
|
(6)
|
(10)
|
(10)
|
(7)
|
(8)
|
(10)
|
(10)
|
(8)
|
(13)
|
(19)
|
(27)
|
(34)
|
(33)
|
(30)
|
(36)
|
|
| Depreciation & Amortization |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
(6)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
3
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(10)
N/A
|
(13)
-26%
|
(12)
+6%
|
(10)
+21%
|
(10)
-3%
|
(13)
-33%
|
(0)
+100%
|
(1)
-1 800%
|
(5)
-547%
|
(3)
+34%
|
(5)
-54%
|
(6)
-25%
|
(5)
+20%
|
(6)
-12%
|
(6)
-15%
|
(8)
-20%
|
(9)
-19%
|
(11)
-24%
|
(15)
-34%
|
(17)
-11%
|
(12)
+30%
|
(7)
+39%
|
(6)
+17%
|
(6)
-7%
|
6
N/A
|
2
-63%
|
(11)
N/A
|
(8)
+23%
|
(9)
-5%
|
(12)
-34%
|
(8)
+29%
|
(7)
+11%
|
(0)
+95%
|
56
N/A
|
205
+267%
|
166
-19%
|
187
+12%
|
194
+4%
|
34
-82%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||
| Interest Income Expense |
0
|
(1)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
(1)
|
(2)
|
1
|
2
|
1
|
0
|
(0)
|
(0)
|
9
|
9
|
(3)
|
(3)
|
(0)
|
1
|
(1)
|
(1)
|
0
|
0
|
1
|
1
|
0
|
1
|
(4)
|
(3)
|
5
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
(6)
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
(3)
|
(3)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(10)
N/A
|
(14)
-40%
|
(12)
+11%
|
(9)
+24%
|
(15)
-66%
|
(13)
+17%
|
(0)
+100%
|
(1)
-3 333%
|
(5)
-401%
|
(3)
+35%
|
(5)
-42%
|
(6)
-27%
|
(5)
+16%
|
(6)
-14%
|
(10)
-80%
|
(12)
-15%
|
(8)
+31%
|
(9)
-13%
|
(14)
-51%
|
(17)
-18%
|
(12)
+28%
|
(7)
+39%
|
3
N/A
|
3
-17%
|
3
+12%
|
(1)
N/A
|
(11)
-1 411%
|
(8)
+29%
|
(9)
-20%
|
(12)
-35%
|
(8)
+37%
|
(7)
+12%
|
0
N/A
|
57
+30 802%
|
205
+261%
|
167
-18%
|
183
+9%
|
191
+4%
|
39
-80%
|
|
| Net Income | ||||||||||||||||||||||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(48)
|
(50)
|
(41)
|
(42)
|
(8)
|
|
| Income from Continuing Operations |
(10)
|
(14)
|
(12)
|
(9)
|
(15)
|
(13)
|
(0)
|
(1)
|
(5)
|
(3)
|
(5)
|
(6)
|
(5)
|
(6)
|
(10)
|
(12)
|
(8)
|
(9)
|
(13)
|
(15)
|
(12)
|
(8)
|
3
|
3
|
3
|
(1)
|
(11)
|
(8)
|
(9)
|
(12)
|
(8)
|
(7)
|
0
|
55
|
157
|
117
|
142
|
149
|
30
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Income (Common) |
(10)
N/A
|
(14)
-40%
|
(12)
+11%
|
(9)
+24%
|
(15)
-67%
|
(13)
+17%
|
0
N/A
|
(1)
N/A
|
(5)
-469%
|
(3)
+35%
|
(5)
-43%
|
(6)
-28%
|
(5)
+16%
|
(6)
-15%
|
(10)
-81%
|
(12)
-15%
|
(8)
+31%
|
(9)
-8%
|
(13)
-49%
|
(15)
-15%
|
(12)
+22%
|
(8)
+32%
|
3
N/A
|
3
-17%
|
3
+12%
|
(1)
N/A
|
(11)
-1 411%
|
(8)
+29%
|
(9)
-20%
|
(12)
-35%
|
(8)
+37%
|
(7)
+12%
|
0
N/A
|
55
+29 815%
|
157
+185%
|
117
-25%
|
142
+21%
|
149
+5%
|
30
-80%
|
|
| EPS (Diluted) |
-1.52
N/A
|
-1.21
+20%
|
-1.64
-36%
|
-0.96
+41%
|
-1.26
-31%
|
-0.99
+21%
|
0.01
N/A
|
-0.04
N/A
|
-0.24
-500%
|
-0.15
+38%
|
-0.12
+20%
|
-0.12
N/A
|
-0.09
+25%
|
-0.11
-22%
|
-0.17
-55%
|
-0.16
+6%
|
-0.11
+31%
|
-0.11
N/A
|
-0.16
-45%
|
-0.18
-12%
|
-0.14
+22%
|
-0.1
+29%
|
0.04
N/A
|
0.03
-25%
|
0.03
N/A
|
-0.01
N/A
|
-0.11
-1 000%
|
-0.08
+27%
|
-0.09
-12%
|
-0.11
-22%
|
-0.07
+36%
|
-0.05
+29%
|
0
N/A
|
0.43
N/A
|
1.24
+188%
|
0.92
-26%
|
1.09
+18%
|
1.14
+5%
|
0.23
-80%
|
|
Switch to:
Switch to:
See Also
Discover More
